| ATE.V - Antibe Therapeutics Inc | |||
|---|---|---|---|
| 31.88 -3.23 (0%) | |||
| Open: | Prev Close: | ||
| High: | Low: | ||
| Volume: | Market Cap: | ||
| Year High: | Year Low: | ||
| Stock Technical Analysis | |
|---|---|
| Overall |  |
| Targets | Six months: 4.65 One year: 5.08 |
| Supports | Support1: 3.38 Support2: 2.81 |
| Resistances | Resistance1: 3.98 Resistance2: 4.35 |
| Pivot Point | 4.03 |
| Moving Averages | MA(5): 3.95 MA(20): 4.01
MA(100): 3.75 MA(250): 4.78 |
| MACD | MACD(12,26): 0.02 Signal(12,26,9): 0.05 |
| Stochastic Oscillator | %K(14,3): 17.64 %D(3): 32.55 |
| RSI | RSI(14): 39.24 |
| 52-Week | High: 8.90 Low: 3.05 Change(%): -27.7 |
| Average Volume(K) | 3-Month: 9423 10-Days: 9529 |
| Moving Averages analysis |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term. |
| Bollinger Bands Analysis |
|---|
| ATE.V has closed below the lower band by 25.2%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 36.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock Technical Analysis Charts |
|---|
|
|
|
| Financials | |
|---|---|
| EPS | -0.067 |
| EPS Est. Current Year | |
| EPS Est. Next Year | |
| EPS Est. Next Quarter | |
| Forward EPS | |
| Shares Out. (M) | 281.28 |
| Shares Float (M) | 252.31 |
| Book Value (p.s.) | 0.030 |
| PEG Ratio | |
| Profit Margin | -167.27 |
| Operating Margin | -157.27 |
| Return on Assets (ttm) | -72.0 |
| Return on Equity (ttm) | -266.6 |
| Qtrly Rev. Growth | 4.4 |
| Gross Profit (p.s.) | 0.014 |
| Sales Per Share | 0.036 |
| EBITDA (p.s.) | -0.055 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -9.23 |
| Levered Free Cash Flow (M) | -4.61 |
| Valuation | |
|---|---|
| P/E | -56.12 |
| P/E Growth Ratio | -0.04 |
| P/BV | 125.33 |
| P/S | 105.03 |
| P/CF | -114.58 |